Low expression of miR-206 in cancerous tissue is linked to poor overall survival of patients [148] The anti-tumor effect of miR-206 in CRC is mediated via targeting various genes such as transmembrane 4 L6 family member 1 (TM4SF1) and VEGF [149]. This evidence concerns the gene TM4SF1 and colorectal carcinoma.